Pfizer Inc
(MIL:1PFE)
€
25
-0.395 (-1.56%)
Market Cap: 140.28 Bil
Enterprise Value: 192.77 Bil
PE Ratio: 36.11
PB Ratio: 1.64
GF Score: 63/100 Pfizer Inc at JPMorgan Healthcare Conference Transcript
Jan 09, 2023 / 11:00PM GMT
Christopher Thomas Schott
JPMorgan Chase & Co, Research Division - Senior Analyst
Good afternoon. I'm Chris Schott at JPMorgan, and it's my pleasure to be hosting a fireside chat today with Albert Bourla, Chairman and CEO of Pfizer. So Albert, happy new year. Thanks for joining us.
Albert Bourla
Pfizer Inc. - Chairman of the Board & CEO
Great to be here. Thank you very much.
Christopher Thomas Schott
JPMorgan Chase & Co, Research Division - Senior Analyst
I know you want to make some opening remarks, and then we can jump into the conversation.
Albert Bourla
Pfizer Inc. - Chairman of the Board & CEO
Yes, I can do that. But first, I want to say that last time we met was in this place, the 2 of us, just before COVID. So how many things have changed since then?
Christopher Thomas Schott;Albert Bourla
JPMorgan Chase & Co, Research Division - Senior Analyst;
Really amazing.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot